Showing results (2451-2460 of 31,410) with videos related to
Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|September 1, 1976
9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, Some behavioral and analgesic properties, and comparison with the tetrahydrocannabinolsR S Wilson, E L MayJournal of Medicinal Chemistry|August 2, 1996
Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptorsD E Patterson, R D Cramer, A M Ferguson, et al.Journal of Medicinal Chemistry|August 2, 1996
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agentsQ Li, D T Chu, A Claiborne, et al.Journal of Medicinal Chemistry|August 2, 1996
De novo antimicrobial peptides with low mammalian cell toxicityM M Javadpour, M M Juban, W C Lo, et al.Journal of Medicinal Chemistry|August 2, 1996
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activityB Gatto, G Zagotto, C Sissi, et al.Journal of Medicinal Chemistry|August 2, 1996
Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetaseS Hibi, Y Okamoto, K Tagami, et al.Journal of Medicinal Chemistry|August 2, 1996
Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidaseC A Fink, J E Carlson, P A McTaggart, et al.Journal of Medicinal Chemistry|August 2, 1996
Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring systemB J Mavunkel, Z Lu, R R Goehring, et al.Journal of Medicinal Chemistry|August 2, 1996
Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailabilityA Fässler, G Bold, H G Capraro, et al.Journal of Medicinal Chemistry|January 5, 1996
Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclamsG J Bridger, R T Skerlj, S Padmanabhan, et al.Pageof 3,141